Assignee
ALIGOS THERAPEUTICS INC
US35 patents
Top patents by PatentIndex Score
US11851422B2Dec 26, 2023
Anti-viral compounds
ALIGOS THERAPEUTICS INC8 citations84
US11091467B2Aug 17, 2021
Modulators of THR-β and methods of use thereof
ALIGOS THERAPEUTICS INC6 citations84
US11952365B2Apr 9, 2024
Anti-viral compounds
ALIGOS THERAPEUTICS INC2 citations72
US11549110B2Jan 10, 2023
Modified short interfering nucleic acid (siNA) molecules and uses thereof
ALIGOS THERAPEUTICS INC5 citations72
US11191747B2Dec 7, 2021
Pyrrole compounds
ALIGOS THERAPEUTICS INC3 citations72
US12018015B2Jun 25, 2024
Methods and compositions for targeting PD-L1
ALIGOS THERAPEUTICS INC2 citations71
US11820773B2Nov 21, 2023
Tricyclic compounds
ALIGOS THERAPEUTICS INC2 citations70
US11136321B2Oct 5, 2021
Tricyclic compounds
ALIGOS THERAPEUTICS INC4 citations70
US11033556B2Jun 15, 2021
Bicyclic sulfonamides
ALIGOS THERAPEUTICS INC1 citations63
US12180192B2Dec 31, 2024
Modulators of THR-β and methods of use thereof
ALIGOS THERAPEUTICS INC0 citations62
US11771680B2Oct 3, 2023
Pyrrole compounds
ALIGOS THERAPEUTICS INC1 citations62
US11466274B2Oct 11, 2022
Modified gapmer oligonucleotides and methods of use
ALIGOS THERAPEUTICS INC1 citations62
US11166976B2Nov 9, 2021
S-antigen transport inhibiting oligonucleotide polymers and methods
ALIGOS THERAPEUTICS INC1 citations62
US12534450B2Jan 27, 2026
Methods and compositions for targeting PD-L1
ALIGOS THERAPEUTICS INC0 citations61
US12252481B2Mar 18, 2025
Anti-viral compounds
ALIGOS THERAPEUTICS INC0 citations61
US12065428B2Aug 20, 2024
Anti-viral compounds
ALIGOS THERAPEUTICS INC1 citations61
US11952374B2Apr 9, 2024
Bicyclic compounds
ALIGOS THERAPEUTICS INC1 citations61
US11760764B2Sep 19, 2023
Methods and compositions for targeting PD-L1
ALIGOS THERAPEUTICS INC2 citations61
US11760761B2Sep 19, 2023
Methods and compositions for targeting PD-L1
ALIGOS THERAPEUTICS INC2 citations61
US11198699B2Dec 14, 2021
Compounds targeting PRMT5
ALIGOS THERAPEUTICS INC1 citations61
US12454691B2Oct 28, 2025
Modified short interfering nucleic acid (siNA) molecules and uses thereof
ALIGOS THERAPEUTICS INC0 citations60
US11957683B2Apr 16, 2024
Bicyclic compounds
ALIGOS THERAPEUTICS INC1 citations60
US12129469B2Oct 29, 2024
Modified short interfering nucleic acid (siNA) molecules and uses thereof
ALIGOS THERAPEUTICS INC1 citations59
US11591341B2Feb 28, 2023
Bicyclic and tricyclic compounds
ALIGOS THERAPEUTICS INC1 citations59
US11613750B2Mar 28, 2023
Methods of reducing virus molecule levels
ALIGOS THERAPEUTICS INC0 citations56
US11858913B2Jan 2, 2024
Bicyclic pyridazinones and methods of use thereof
ALIGOS THERAPEUTICS INC0 citations52
US11840532B2Dec 12, 2023
Modulators of THR-β and methods of use thereof
ALIGOS THERAPEUTICS INC0 citations52
US11793815B2Oct 24, 2023
Oxindoles and methods of use thereof
ALIGOS THERAPEUTICS INC0 citations52
US11786532B2Oct 17, 2023
2-pyridones and methods of use thereof
ALIGOS THERAPEUTICS INC0 citations52
US11939581B2Mar 26, 2024
Methods and compositions for targeting PD-L1
ALIGOS THERAPEUTICS INC0 citations51
US12428427B2Sep 30, 2025
Methods and compositions for targeting PD-L1
ALIGOS THERAPEUTICS INC0 citations50
US12384779B2Aug 12, 2025
Bicyclic compounds
ALIGOS THERAPEUTICS INC0 citations50
US11845752B2Dec 19, 2023
Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B
ALIGOS THERAPEUTICS INC0 citations50
US11787833B2Oct 17, 2023
Modified cyclic dinucleoside compounds as sting modulators
ALIGOS THERAPEUTICS INC0 citations50
US11464783B2Oct 11, 2022
Heterocyclic compounds
ALIGOS THERAPEUTICS INC0 citations50